Literature DB >> 402576

Foundations of cost-effectiveness analysis for health and medical practices.

M C Weinstein, W B Stason.   

Abstract

Limits on health-care resources mandate that resource-allocation decisions be guided by considerations of cost in relation to expected benefits. In cost-effectiveness analysis, the ratio of net health-care costs to net health benefits provides an index by which priorities may be set. Quality-of-life concerns, including both adverse and beneficial effects of therapy, may be incorporated in the calculation of health benefits as adjustments to life expectancy. The timing of future benefits and costs may be accounted for by the appropriate use of discounting. Current decisions must inevitably be based on imperfect information, but sensitivity analysis can increase the level of confidence in some decisions while suggesting areas where further research may be valuable in guiding others. Analyses should be adaptable to the needs of various health-care decision makers, including planners, administrators and providers.

Mesh:

Year:  1977        PMID: 402576     DOI: 10.1056/NEJM197703312961304

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  285 in total

1.  Asthma outcome measures.

Authors:  K D Watkins
Journal:  J Med Syst       Date:  1999-08       Impact factor: 4.460

2.  The discount rate in the economic evaluation of prevention: a thought experiment.

Authors:  L Bonneux; E Birnie
Journal:  J Epidemiol Community Health       Date:  2001-02       Impact factor: 3.710

3.  Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease.

Authors:  K Stavem
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

Review 4.  Cost utility analysis of radiographic screening for an orbital foreign body before MR imaging.

Authors:  D J Seidenwurm; C H McDonnell; N Raghavan; J Breslau
Journal:  AJNR Am J Neuroradiol       Date:  2000-02       Impact factor: 3.825

5.  Radiographic screening for orbital foreign bodies prior to MR imaging: is it worth it?

Authors:  J G Jarvik; S Ramsey
Journal:  AJNR Am J Neuroradiol       Date:  2000-02       Impact factor: 3.825

6.  Pharmacoeconomics and health policy. Current applications and prospects for the future.

Authors:  P E Greenberg; A Arcelus; H G Birnbaum; P Y Cremieux; J LeLorier; P Ouellette; M B Slavin
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

Review 7.  Methodological hurdles in conducting pharmacoeconomic analyses.

Authors:  J D Rizzo; N R Powe
Journal:  Pharmacoeconomics       Date:  1999-04       Impact factor: 4.981

8.  Economic notes: definitions of efficiency.

Authors:  S Palmer; D J Torgerson
Journal:  BMJ       Date:  1999-04-24

Review 9.  Pharmacoeconomics of influenza vaccination in the elderly: reviewing the available evidence.

Authors:  M J Postma; R M Baltussen; M L Heijnen; L T de Berg; J C Jager
Journal:  Drugs Aging       Date:  2000-09       Impact factor: 3.923

Review 10.  Fundamentals of clinical economics in health interventions.

Authors:  S Awasthi
Journal:  Indian J Pediatr       Date:  2000-05       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.